Genenta Science Spa Stock Price on September 30, 2024
| GNTA Stock | USD 4.78 0.01 0.21% |
If you're considering investing in Genenta Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genenta Science stands at 4.78, as last reported on the 27th of November, with the highest price reaching 4.90 and the lowest price hitting 4.69 during the day. Genenta Science appears to be very risky, given 3 months investment horizon. Genenta Science SpA holds Efficiency (Sharpe) Ratio of 0.0716, which attests that the entity had a 0.0716% return per unit of risk over the last 3 months. We have found thirty technical indicators for Genenta Science SpA, which you can use to evaluate the volatility of the firm. Please utilize Genenta Science's Downside Deviation of 5.85, risk adjusted performance of 0.0636, and Market Risk Adjusted Performance of (1.71) to validate if our risk estimates are consistent with your expectations.
Genenta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Genenta |
Sharpe Ratio = 0.0716
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GNTA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.66 actual daily | 59 59% of assets are less volatile |
Expected Return
| 0.48 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Genenta Science is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genenta Science by adding it to a well-diversified portfolio.
Related Headline
MediciNova Headline on 30th of September 2024
MNOV MN-166 to be Evaluated in NIH-Sponsored Expanded Access... by finance.yahoo.com
By David Bautz, PhD NASDAQMNOV READ THE FULL MNOV RESEARCH REPORT On September 30, 2024, MediciNova, Inc. announced that MN-166 will be evaluated in an Expanded Access Protocol trial to evaluate its efficacy in patients with amyotrophic lateral sclerosis . The EAP is being supported through a 22 million grant from the National Institutes of Health
Genenta Science Valuation on September 30, 2024
It is possible to determine the worth of Genenta Science on a given historical date. On September 30, 2024 Genenta was worth 4.17 at the beginning of the trading date compared to the closed value of 4.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genenta Science stock. Still, in general, we apply an absolute valuation method to find Genenta Science's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genenta Science where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genenta Science's related companies.
| Open | High | Low | Close | Volume | |
| 4.13 | 4.41 | 3.86 | 3.92 | 8,768 | |
09/30/2024 | 4.17 | 4.50 | 3.91 | 4.27 | 25,550 |
| 4.03 | 4.20 | 4.01 | 4.08 | 12,741 |
| Backtest Genenta Science | | | Genenta Science History | | | Genenta Science Valuation | Previous | Next |
Genenta Science Trading Date Momentum on September 30, 2024
| On October 01 2024 Genenta Science SpA was traded for 4.08 at the closing time. The top price for the day was 4.20 and the lowest listed price was 4.01 . The trading volume for the day was 12.7 K. The trading history from October 1, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.45% . The overall trading delta against the current closing price is 37.00% . |
Genenta Science SpA Fundamentals Correlations and Trends
By evaluating Genenta Science's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genenta Science's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genenta financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Genenta Science Stock history
Genenta Science investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genenta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genenta Science SpA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genenta Science stock prices may prove useful in developing a viable investing in Genenta Science
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company was incorporated in 2014 and is headquartered in Milan, Italy. Genenta Science is traded on NASDAQ Exchange in the United States.
Genenta Science Stock Technical Analysis
Genenta Science technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Genenta Science Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Genenta Science SpA cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Genenta Science November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Genenta Science stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genenta Science shares will generate the highest return on investment. By undertsting and applying Genenta Science stock market strength indicators, traders can identify Genenta Science SpA entry and exit signals to maximize returns
Genenta Science Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genenta Science's price direction in advance. Along with the technical and fundamental analysis of Genenta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genenta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0636 | |||
| Jensen Alpha | 0.4999 | |||
| Total Risk Alpha | (0.58) | |||
| Sortino Ratio | 0.0593 | |||
| Treynor Ratio | (1.72) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Genenta Stock analysis
When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |